government
FDA panel votes to add peptides to permitted list despite opposition from agency scientists
Summary by The El Paso Editorial Desk · Based on reporting by Joseph Choi and The Hill , KTSM 9 News (NBC)
· July 24, 2026
· 1 min read
The Food and Drug Administration's (FDA) committee on compounded drugs on Thursday broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make, despite concerns being raised over the lack of demonstrated benefits.
Story provenance No corrections
Summary created by The El Paso Editorial Desk — automated, rule-governed Original reporting Joseph Choi and The Hill, KTSM 9 News (NBC) Original story Read at the source Source published Jul 24, 2026 Indexed here Jul 24, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Why this matters in The El Paso
El Paso residents who rely on compounded medications from local pharmacies may soon have access to a broader range of treatments, as the FDA committee's decision could pave the way for compounding pharmacies in the city to produce peptides. This development is particularly relevant for El Paso's elderly population and those with chronic conditions, who often require customized medications that are not readily available through traditional pharmaceutical channels. The FDA's decision may also have implications for the city's healthcare economy, as local compounding pharmacies could see an increase in demand for their services. However, the concerns raised by agency scientists over the lack of demonstrated benefits of peptides will likely be closely watched by El Paso's medical community, which will be looking for evidence of the safety and efficacy of these substances in treating various health conditions.
About this story
Original reporting by KTSM 9 News (NBC) . The El Paso surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KTSM 9 News (NBC) . Have a tip or correction? Contact our newsroom .
Category: government ·
Published: July 24, 2026 ·
Source: KTSM 9 News (NBC) ·
Reading time: 1 min
Frequently asked about this story
What is this story about? The Food and Drug Administration's (FDA) committee on compounded drugs on Thursday broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make, despite concerns being raised over the lack of demonstrated benefits.
When was this published? This article was first published on July 24, 2026 by KTSM 9 News (NBC) and curated for The El Paso readers.
Who reported this story? This story was reported by Joseph Choi and The Hill at KTSM 9 News (NBC). To learn more about how The El Paso selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more government coverage from The El Paso, or browse our daily briefing and topic hubs .
← Back to all news
More government →
Today’s briefing
Subscribe to newsletter